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A series of well-known, puriﬁed antioxidants including: Resveratrol, Epigallocatechin Gallate (EGCG), Genistein, Rosavin,
Puerarin, Chlorogenic Acid, Propolis and two newer unexplored isoﬂavonoids isolated from Maclura pomifera (Osage Orange)
including Pomiferin and Osajin, were applied to Normal Human Dermal Fibroblasts (NHDF) and Normal Human Dermal
Keratinocytes (NHEK) for 24 hours. The resulting treated cells were then examined using human gene microarrays supplied by
Agilent. These chips typically have somewhere on the order of 30,000 individual genes which are expressed in the human genome.
For our study, this large list of genes was reduced to 205 principal genes thought to be important for skin and each individual
ingredient was examined for its inﬂuence on the culled list of genes. Working on a hypothesis that there may be some common
genes which are either upregulated or downregulated by all or most of these ingredients, a short list of genes for each cell line was
developed. What appears to emerge from these studies is that several genes in the gene pool that was screened are inﬂuenced by
most or all of the molecules of interest. Genes that appear to be upregulated in both cell lines by all the ingredients include: ACLY,
AQP3, COX1, NOS3, and PLOD3. Genes that appear to be downregulated in both cell lines by all ingredients include only PGR.
1.Introduction
A PubMed (http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=
&db=pubmed) search using the following keywords,
“Antioxidant + Skin”, will return approximately 7786
individual journal hits. The earliest references are papers
examining Vitamin E in dermatology and Ascorbic Acid
use in skin tuberculosis dated to 1950. Expanding the
search to the following keywords “Antioxidants + Skin +
Review” provides approximately 878 individual journal hits.
These searches demonstrate very clearly that the ﬁeld of
antioxidant research related to skin is replete with individual
contributions examining antioxidant activity and skin
biology including, for example, the role of plant extracts,
vitamins, and minerals in skin antioxidant applications.
There have been some very good fundamental references
on the role of antioxidants in human health and in particular
as they apply to the skin. Important references are those
edited by Mukhtar [1], Packer and Cadenas [2]a n dP a c k e r
and Valacchi [3]. While it would be nearly impossible to
summarize all the pertinent references on antioxidants and
their role in skin pharmacology and physiology, several
recent references of interest include papers by Cooke and
Evans [4], Nicholas and Katiyar [5], Epstein [6], Ditre et al.
[7],AllemannandBaumann[8]andArctandPytkowska[9].
However, cutaneous research examining the inﬂuence of
antioxidants from a genomic perspective is presently lacking.
There have been some studies examining the global genomic
eﬀects of antioxidants on dietary health [10]. In addition,
somestudiesreportexamininguniquecellsline,inparticular
cancer cell lines, as they respond to antioxidant treatments
using human genomic test methods [11]. A paper recently
published examined the eﬀects of UV light on dorsal root
ganglion and the subsequent eﬀects of the nutrient media
from the irradiated nerve cells on NHEK using human
microarrays [12].
In the present work, normal human dermal ﬁbrob-
lasts (NHDFs) and normal human epidermal keratinocytes2 Mediators of Inﬂammation
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Figure 1: Chemical structure of antioxidant ingredients tested.Mediators of Inﬂammation 3
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Figure 2: Ratio of Medians for genes shown in Table 2 for all individual product treatments on NHEK and NHDF.
(NHEKs) were treated with various well-known antioxi-
dants including Resveratrol [13], Epigallocatechin Gallate
(EGCG) [14], Genistein [15], Rosavin [16], Puerarin [17],
Chlorogenic Acid [18], Propolis [19], and two newer unex-
plored isoﬂavonoids isolated from Maclura pomifera (Osage
Orange) which include Pomiferin and Osajin [20]. Treat-
ment of the individual cell lines for 24 hours with puriﬁed
samples of the antioxidants was followed by examination of
the treated cells using human microarray analysis. A working
hypothesis which guided this study was that there may be
common genomic inﬂuences which all antioxidants have on
skin cells that are the more critical genes that provide the
beneﬁcial eﬀects of the antioxidants.
2.MaterialsandMethods
The individual ingredients used in this study were examined
for their cytotoxicity on Normal Human Dermal Fibroblasts
and Normal Human Epidermal Keratinocytes using the
standardMTTassay.Wherepossible, thesamples weretested
at similar concentrations of 0.01% unless the ingredients
proved to be either cytotoxic or well tolerated at a higherMediators of Inﬂammation 5
Table 1: Concentrations of various ingredients tested on Ker-
atinocytes and Fibroblasts.
Ingredient Keratinocytes Fibroblasts
Pomiferin 0.01% 0.01%
Osajin 0.0001% 0.0001%
Puerarin 0.1% 0.1%
Rosavin 0.01% 0.01%
Chlorogenic Acid 0.001% 0.001%
EGCG 0.01% 0.01%
Genistein 0.01% 0.01%
Resveratrol 0.05% 0.05%
Propolis 0.10% 0.10%
dose. In which case, they were tested at the highest nonlethal
dose possible. Two exceptions were Puerarin and Propolis
which were tested at 0.1% in these studies. The chemical
structures of all the ingredients except Propolis are shown
below. Propolis was exceptional in this study as it is a
composition extracted from Honeycomb which is a complex
combination of polyphenols, isoﬂavonoids, and ﬂavonoids.
The Propolis used in this study was supplied by Lisoma
and is suggested to be 80% pure in propolis content.
Resveratrol (99%), Genistein (>95%), and Chlorogenic Acid
(>95%), were purchased from Sigma Chemical Company
and were used without further puriﬁcation. Puriﬁed Rosavin
(96%), EGCG (97%), and Puerarin (96%), were provided
by Chromadex Chemical Company. Pomiferin (95%) and
Osajin (90%) were provided by Gaia Chemical. All chemical
purities were veriﬁed by HPLC analysis. Chemical structures
for the various test materials are shown in the compiled
Figure 1. The concentrations of the actives tested on NHEK
and NHDF are shown in Table 1.
Human epidermal keratinocytes and dermal ﬁbroblasts
were obtained from Cascade Biologics. Keratinocytes were
grown in Epilife media (supplemented per the manufac-
turer’s recommendation) while ﬁbroblasts were grown in
DMEM (supplemented with 1.5% fetal bovine serum for
the array treatments). Both cell types were seeded into T-25
ﬂasksandgrownat37±2◦Cand5±1%CO2 untilconﬂuent.
Upon reaching conﬂuency the cells were treated with the
various antioxidants (dissolved in DMSO if needed, with a
ﬁnal DMSO concentration in the media of 1%) for 24 hours.
Afterthe24hourtreatment,totalRNAwasisolatedusing
anRNAqueousKit(Ambion)perthemanufacturer’sinstruc-
tions. After puriﬁcation, the total RNA was prepared for
array use by ﬁrst amplifying the RNA using a MessageAmp
aRNA Kit (Ambion), and then ﬂuorescently labeling the
aRNA with Cy3 or Cy5 using an ASAP Labeling Kit (Perkin
Elmer), both per the manufacturer’s instructions. To purify
the ﬂuorescently labeled aRNA, a microcon YM-30 ﬁlter
column was inserted into a collection tube and ﬁlled with
400μlo fT Eb u ﬀer. The Cy3 and Cy5 probes were combined
and then added to the microcon ﬁlter and thoroughly mixed
with the TE buﬀer. The ﬁlter was centrifuged at 12,000RPM
for 8 minutes and the ﬂow through was discarded. The
column was then washed twice with 400μlo fT Eb u ﬀer,
discarding the ﬂow though each time. After the ﬁnal wash
the ﬁlter column was inverted, placed into a new collection
tube and centrifuged at 2,000RPM for 2 minutes to collect
the probe.
The ﬂuorescently labeled aRNA was applied to the DNA
microarray chips (Agilent Technologies) and the chip was
hybridized overnight and washed per the manufacturer’s
recommended protocol. After washing, the microarrays were
scanned with an Axon GenePix 4100A Scanner with the
scanning resolution set to 5μm and analyzed with GenePix
Pro software. During the initial scan the PMT gains for the
scanner were adjusted such that the cy5/cy3 image count
ratios are between 0.88 and 1.12.
Fluorescence intensities for the microarrays were sub-
jected to global normalization. The total ﬂuorescent signal
for both dyes was normalized with a correction factor that
would make the ratio of total intensities for both dyes
equal to one. For this study a Cy3/Cy5 (untreated/treated)
ﬂuorescence intensity ratio greater than 1.3 or less than 0.7
(this relates to a change in gene expression of at least ±30%)
was used as the cutoﬀ for up- and downregulated genes,
respectively. This is referred to as the “ratio of medians”
in the array summaries. This cutoﬀ ratio falls within the
typical range of cutoﬀ ratios found in the literature [21]. In
addition, the ﬂuorescence intensity of the gene marker had
to be greater than the background intensity.
3. Results and Discussion
A summary of the genes examined in these studies is shown
in Table 2. Selection of the genes was principally the eﬀort
of the authors to narrow the extensive list of genes found in
each array to some key target genes felt to be critical for skin.
Genes shown in the Table 1 are not grouped in any particular
order; they are shown alphabetically as they appear in the
arrays.
Provided in Figure 2 are summary graphs showing the
Ratio of Median (ROM), vide supra, for the compiled gene
data examined for the various ingredients tested at the
concentrations speciﬁed in the Methods section on either
NHEK or NHDF as indicated.
Selection of genes of interest was done to cover a broad
range of skin functions including, for example, extracellu-
lar matrix protein expression, lipid synthesis, energy and
metabolism, intrinsic antioxidant synthesis, ROS and DNA
repair response, skin polysaccharide and glycoprotein syn-
thesis, hormone response, longevity, cellular diﬀerentiation,
nerve growth and protection, retinol response, circadian
inﬂuences and skin pigmentation.
Determination of which genes appear to be regularly
up- or downregulated by the majority of the antioxidants
examined was done by comparing the data across each gene
and test material looking for genes that showed Ratio of
Medians greater than 1.3 or less than 0.7 consistently. If
more than four of the entries showed data suggesting either
upregulation or downregulation, the gene set was included.
The summary of the genes that were noted to be either
upregulated or downregulated is provided in Tables 3, 4, 5,
and 6. It seems that the keratinocytes respond more broadly6 Mediators of Inﬂammation
Table 2: Summary of Genes Examined.
Gene Symbol Gene Symbol Gene Symbol Gene Symbol Gene Symbol
ACLY DHCR24 KLK7 POMC USF1
AGER DHCR7 KRT1 PPARA UVRAG
AGK DPT KRT5 PPARD VDR
AIFM1 DSG3 KRT15 PPARG VEGFA
AQP1 EGF LAD1 PRDX1 XPA
AQP3 EGFR LAMA3 PRDX2 XPC
AR ELN LAMB1 PRDX5
ARPC1A ENDOG LAMC1 PTDSS1
ARPC3 ESR1 LIAS PTGER1
ATM ESR2 LIG1 RAD23A
ATR FAP LOR RAD23B
BCDO2 FBN1 LOX RARA
BCL2 FBN2 LSS RARB
BCL2 FGF1 MC1R RARG
BCL2A1 FGF2 MCHR1 RBP1
BCL2L1 FGFR1 MLPH RXRA
BECN1 FLG MMP1 RXRB
CASP7 FLNA MMP2 SCEL
CASP14 FN1 MOAP1 SIRT1
CAT FOXO3A MTCH1 SIRT2
CCS FSHR MTCO1 SIRT3
CD44 GAPDH MTCO2 SIRT4
CDH1 GLRX2 MTNR1A SIRT5
CH25H GPX1 MVD SIRT6
CIRBP GPX4 MVK SIRT7
CLOCK GPX5 NAGK SOD1
COL1A1 GRN NFKB SOD2
COL1A2 GSR NGB SOD3
COL4A1 HAS1 NGFB SPON1
COL4A2 HAS2 NGFRAP1 SQLE
COL6A1 HIF1A NOS1 SRD5A1
COL7A1 HIF3A NOS2 SRD5A2
COL17A1 HMGCR NOS3 TDG
COQ10A HSPA1A NOSTRIN TERT
COX1 HSPA5 OA1 TGFA
CRABP1 HSPB1 OGG1 TGFB1
CRABP2 HYAL1 OXR1 TGM1
CYGB HYAL2 OXSR1 TGM3
CYP46A1 IGF1 P4HA1 TIMELESS
CYP51A1 IGF2 P4HA2 TIMP1
DDB1 IGF1R P4HB TIMP2
DDB2 IL1A PAK2 TIMP4
DDIT3 IL1B PER1 TNF
DDIT4 ITGA1 PER2 TP53
DDI2 ITGA5 PGM1 TPT1
DDT ITGA6 PGR TRPV1
DEFA3 ITGA7 PLOD TXN
DEFB1 IVL PLOD2 TYR
DEFB104 KL PLOD3 TYRP1
DEFB4 KLK5 PNN UNGMediators of Inﬂammation 7
Table 3: Summary of ﬁbroblasts genes noted to be commonly upregulated by the antioxidant treatments.
FIBROBLASTS Test Materials Pomiferin Osajin Resveratrol EGCG Genistein Rosavin Puerarin Chlorogenic
Acid
Propolis
Gene Name Gene Description
ACLY ATP citrate lyase 1.874 1.334 1.229 1.896 0.582 1.248 1.504 0.766 1.254
AQP1 Aquaporin 1 2.232 1.915 1.093 2.166 0.472 1.531 1.436 1.231 1.499
COL1A1 Collagen, Type 1,
alpha 1
2.446 1.36 1.074 1.423 0.757 1.237 1.017 2.26 1.496
COX1 Cytochrome c
oxidase 1
1.875 2.089 1.288 1.929 0.699 1.623 1.178 2.252 1.485
GRN Granulin 1.394 1.25 1.233 1.444 0.753 1.288 1.13 1.502 1.478
NOS3 Nitric oxide
synthase 3
1.478 1.607 1.39 2.061 0.717 1.459 1.527 0.874 1.302
PLOD3 Lysine hydroxylase 3 1.782 1.367 1.573 1.16 0.687 1.442 1.404 3.805 1.186
RARA Retinoic acid
receptor, alpha
1.72 1.513 1.534 1.36 0.706 1.211 1.379 1.423 1.034
TXN Thioredoxin 1.956 1.767 1.387 2.164 0.692 1.538 1.341 3.556 2.229
Table 4: Summary of ﬁbroblasts genes noted to be commonly downregulated by the antioxidant treatments.
FIBROBLASTS Test Materials Pomiferin Osajin Resveratrol EGCG Genistein Rosavin Puerarin Chlorogenic
Acid
Propolis
Gene Name Gene Description
DSG3 Desmoglein 3 0.847 0.545 0.708 0.667 −0.118 0.385 0.438 0.46 0.737
HAS1 Hyaluronan
synthase 1
1.091 0.667 0.526 0.615 0.695 0.429 0.462 1.5 0.385
ILIA Interleukin 1, alpha 1.2 0.599 0.588 0.556 −0.27 0 0.5 0.517 0.5
KL Klotho 1.136 0.731 0.56 0.7 0.099 0.167 0.588 0 0.7
NOS2 Nitric oxide
synthase 2
0.831 0.694 0.655 0.928 0.303 0.441 0.588 1.05 0.724
PGR Progestone receptor 0.764 0.926 0.579 0.571 0.337 0.364 0.583 0 0.545
to the antioxidant treatments than the ﬁbroblasts as noted
by the greater preponderance of gene responses, both up and
down, for the keratinocytes verses the ﬁbroblasts.
In reviewing the data compiled in Tables 3–6, it is possi-
ble to narrow the genes that are “universally” upregulated or
do wnr egulatedforeachc ellline.I tisnotedthatthefollo wing
genes are upregulated in both ﬁbroblasts and keratinocytes:
ACLY, AQP3, COX1, NOS3, and PLOD3. Interestingly, only
one gene is commonly downregulated in both cell lines by
the majority of the antioxidant treatments: PGR.
Demonstrating that the Progesterone Receptor (PGR)
gene would be downregulated by the majority of the ingredi-
ents examined in these studies in both cell lines suggests that
this particular gene and its corresponding protein may play a
more pivotal role in the behavior of these ingredients on skin
thanpreviouslyrealized.Ithasbeenshownthatprogesterone
applied to the skin of monkeys suppresses estrogen receptor
expression [22–24]. In reviewing the eﬀect of these ingredi-
ents on the estrogen receptor gene expression (Table 7) there
appears to be little indication that these molecules stimulate
expression of the two key estrogen receptor genes. In most
cases, the ingredients had no eﬀect on the estrogen receptor
gene expressions (indicated by Ratio of Medians between
0.7 and 1.3). This suggests that while it is well known that
some molecules such as genistein can bind to the estrogen
receptors it seems unlikely that all of these molecules would
do so. What may be happening with many (or all) of these
unique ingredients on skin could be an altering of the
estrogen/progesterone receptor protein ratio for each cell
line. If these molecules universally suppress expression of
the progesterone receptor proteins while not inﬂuencing the
expression of the estrogen receptor proteins, this may cause
a change in the critical ratio of these two key proteins. In
this case, what appears as an estrogenic eﬀect is, instead, a
suppression of progesterone eﬀects due to a diminishment
in expression of the receptor proteins. This suggests that the
term “phytoestrogen” often used to describe molecules like
genistein may be somewhat of a misnomer and the bulk
of these topically beneﬁcial molecules are actually “anti-
phytoprogesterones”. Most certainly, the majority of the
ingredients examined in this study appear to be progesterone
receptor gene antagonists although conﬁrmation of these
inﬂuences via protein assays remains to be done.
Valacchi et al. have examined the role of antioxi-
dants in skin stressed with the oxidizer ozone, looking at
the antioxidant β-Carotene in particular. These authors8 Mediators of Inﬂammation
Table 5: Summary of keratinocyte genes noted to be commonly upregulated by the antioxidant treatments.
KERATINOCYTES Test Materials Pomiferin Osajtn Resveratrol EGCG Genistein Rosavin Puerarin Chlorogenic
Acid
Propolis
Gene Name Gene Description
ACLY ATP citrate lyase 3.499 1.769 1.46 1.047 0.887 1.319 1.461 0.981 1.541
AQP1 Aquaporin 1 3.288 2.098 1.575 0.436 0.947 1.34 1.757 2 1.736
AQP3 Aquaporin 3 1.65 1.055 1.598 1.636 2.587 1.17 1.418 1.319 1.451
CD44 Transmembrane
glycoprotein CD44
2.312 1.345 1.236 0.867 1.504 0.758 1.07 1.34 1.398
CDH1 Cadherin 1 2.489 1.489 1.599 0.989 1.152 0.934 1.379 1.582 1.422
COX1 Cytochrome c
oxidase 1
2.637 2.045 1.421 0.985 0.914 1.354 1.217 2.499 2.149
FGFl Fibroblast growth
factor 1
2.65 1.67 1.519 0.194 0.316 1.303 1.345 3 0.945
GRN Granulin 2.976 1.652 1.496 0.959 0.936 1.281 1.297 1.452 1.57
HSPB1 Heat Shock 27kD
protein 1
2.991 1.437 1.539 1.028 0.922 1.406 1.42 2.581 1.768
KRT5 Keratin 5 2.964 2.197 1.704 1.008 0.573 1.258 1.134 2.439 2.141
NOS3 Nitric oxide
synthase 3
3.152 1.859 1.609 0.981 0.893 1.277 1.311 1.041 1.812
PLOD3 Lysine hydroxylase 3 3.231 1.94 1.45 1.102 0.917 1.299 1.481 2.671 1.756
TPTl Histamine-releasing
factor
2.813 2.148 1.617 1.105 0.925 1.363 1.431 2.184 1.874
TXN Thioredoxin 2.41 1.924 1.369 0.985 0.83 1.352 1.206 2.244 2.026
looked at inﬂammatory markers such as iNOS [NOS1] and
Hemeoxygenase-1 [HO1] when skin is stressed with ozone
and the role that β-Carotene plays in minimizing inﬂam-
matory response [25]. They noted that in the presence of
an external oxidative stress such as ozone, antioxidants such
as β-Carotene will generally downregulate inﬂammatory
markers such as those noted above. However, without the
presence of an external oxidative threat, it was found in the
currentstudiesthatinbothcelllines,directapplicationofthe
antioxidants used in these studies under ambient conditions
resulted in upregulation of the inﬂammatory mediators
COX1 and NOS3 [26–29]. This is somewhat surprising
as typically commercial descriptions of antioxidants often
suggest they are soothing or calming. It would seem that
just the opposite may be occurring and the majority of
the various antioxidants tested here cause inﬂammatory-like
responses in the skin cells. However, the close balance the
body and skin maintain between healing and inﬂammation
may suggest that there is a common inﬂuence of the majority
of these antioxidants to stimulate a healing type response in
the skin cells. There appears to be an inverse relationship
between COX1 expression and Progesterone expression, so
the possibility that the PGR gene is downregulated by
ingredients that also appear to upregulate COX1 may be
expected [30].
The common upregulation of ATP-Citrate Lyase (ACLY)
in both cell lines by the majority of the antioxidants is
also quite interesting [31, 32]. ATP-Citrate Lyase is a critical
enzyme responsible of de novo fatty acid synthesis respon-
sible for generating cystolic acetyl-CoA and oxaloacetate.
Acetyl-CoA is one of the essential building blocks for lipid
synthesis in the body. Common upregulation of this gene
suggests that the majority of the antioxidants tested here
may be inﬂuencing skin lipid synthesis. This would support
the beneﬁcial eﬀects of the ingredients on the skin as well,
particularly for barrier repair and improvements.
Aquaporin-3 has only recently emerged as a critical
protein in skin [33, 34]. The protein is known to be
expressed in both keratinocytes and ﬁbroblasts. The protein
controls water ﬂux within the skin cells. In ﬁbroblasts and
keratinocytes, the Aquaporin-3 protein has been suggested
to be involved in wound healing through cell migration
processes [33]. Its common upregulation by the antioxidants
in this study suggests a key role for this protein in improved
skin health and cell turnover as well as playing an important
role in skin hydration.
Lysine hydroxylase-3 (PLOD3) is the gene responsible
for expression of a protein that helps crosslink collagen and
elastin ﬁbers via hydroxylation of lysine and proline residues
[35]. Its expression in ﬁbroblasts is well established, however,
it is unclear if it is expressed in keratinocytes or not. It
can be noted that topical application of the majority of
the isoﬂavonoids tested causes upregulation of PLOD3 in
both ﬁbroblasts and keratinocytes. Certainly, upregulation
of PLOD3 would be consistent with the ﬁnding that topical
applications of isoﬂavonoids lead to ﬁrmer looking skin as
increased crosslinking of collagen would lead to a rebuilding
eﬀect in aging skin.
While it is desirable to think that the bulk of the
molecules tested here work through some uniform mech-
anistic pathways, this idea may be somewhat naive. How-
ever, by examining multiple structurally unique moleculesMediators of Inﬂammation 9
Table 6: Summary of keratinocyte genes noted to be commonly downregulated by the antioxidant treatments.
KERATINOCYTES Test Materials Pomiferin Osajin Resveratrol EGCG Genistein Rosavin Puerarin Chlorogenic
Acid
Propolis
Gene Name Gene Description
AR Androgen receptor 0.06 0.462 0.607 0.257 0.302 0.417 0.581 0 0.459
CYGB Cytoglobin 0.175 0.414 0.636 0.319 0.242 0.268 0.571 0.688 0.667
EGF Epidermal growth
factor
0.159 0.52 0.741 0.25 0.204 0.272 0.516 0.471 0.774
ESR2 Estrogen receptor 2 0.093 0.444 0.706 0.192 0.727 0.26 0.478 0 0.438
FBN1 Fibrillin 1 0.52 0.78 0.75 0.215 0.214 0.337 0.667 0.563 0.612
FBN2 Fibrillin 2 0.731 0.917 0.857 0.32 0.473 0.541 0.693 0.571 0.634
IGF1 Insulin growth factor 1 0.135 0.588 0.6 0.31 0.429 0.381 0.5 0 0.462
KL Klotho 0.038 0.273 0.545 0.357 0.278 0.181 0.444 0 0.4
MC1R Melanocortin 1
receptor
0.167 0.571 0.619 0.302 0.433 0.19 0.561 2 0.538
PGR Progestone receptor 0.052 0.538 0.8 0.304 0.217 0.293 0.235 2 0.5
POMC Proopiomelanocortin 0.194 0.483 0.75 0.295 0.452 0.357 0.788 0.982 0.738
PPARG
Peroxisome
proliferator activated
receptor, gamma
0.154 0.563 0.571 0.314 0.129 0.538 0.45 0.333 0.438
PTGER1 Prostaglandin E
receptor 1
0.107 0.6 0.667 0.209 0.235 0.245 0.657 1.25 0.629
RAD23A R A D 2 3h o m o l o gA 0.391 0.482 1.034 0.385 0.414 0.578 0.971 0.577 0.789
RXRA Retinoid X receptor,
alpha
0.636 0.445 0.409 0.561 0.621 0.689
SOD3 Superoxide dismutase 3 0.13 0.571 0.467 0.276 0.431 0.617 0.6 0.571 0.778
SRD5A2 Steroid 5
alpha-reductase A2
0.097 0.556 0.636 0.371 0.333 0.588 0.529 0.5 0.583
TERT Telomerase reverse
transcriptase
0.311 0.595 0.619 0.298 0.394 0.436 0.556 0.709 0.756
TYRP1 Tyrosinase related
peptide 1
0.043 0.852 0.611 0.34 0.244 0.296 0.7 0.5 0.5
Table 7: Summary of Ratio of Medians for ingredient inﬂuences on estrogen receptor gene expression.
Pomiferin (ROM) Osajin Resveratrol EGCG Genistein Rosavin Puerarin Chlorogenic Acid Propolis
Keratinocyte Gene
ESR1 (Estrogen Receptor 1) 0.538 0.824 1.111 0.205 0.22 0.744 0.988 0.714 0.795
ESR2 (Estrogen Receptor 2) 0.093 0.444 0.706 0.192 0.727 0.26 0.478 0 0.438
Fibroblast Gene
ESR1 (Estrogen Receptor 1) 0.824 0.728 0.784 0.65 0.664 0.294 0.708 0.5 1
ESR2 (Estrogen Receptor 2) 0.828 0.864 0.5 0.333 0.984 0 0.545 1 0.7
well-known to inﬂuence skin structure and function, a
clearer picture of the genomic eﬀects of these ingredients on
skinmaybegintobeelucidated.Certaintargets,inparticular,
the unusual ﬁnding that the bulk of these ingredients appear
to downregulate Progesterone Receptor gene expression,
warrant further protein work to verify if this is indeed the
case. It may be that while unique in chemical structure,
common pathways to improved skin appearance are not as
unique to the molecules tested, but rather to the targets that
theyaddressuniversally.Theabilitytoexaminemultiplegene
expression eﬀects using human microarrays will open future
doors to answer these types of questions.
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